Price T Rowe Associates Inc Guardant Health, Inc. Transaction History

Price T Rowe Associates Inc

$836 Billion
Q2 2024

A detailed history of Price T Rowe Associates Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,375,674 shares of GH stock, worth $40.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,375,674

Previous 1,545,114 10.97%

Holding current value

$40.9 Million

Previous $31.9 Million 24.64%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$16.07 - $31.84 $2.72 Million - $5.39 Million	-169,440 Reduced 10.97%	1,375,674 $39.7 Million
Q1 2024 May 15, 2024	SELL	$17.13 - $26.91 $4.7 Million - $7.39 Million	-274,470 Reduced 15.08%	1,545,114 $31.9 Million
Q4 2023 Feb 14, 2024	SELL	$21.58 - $29.5 $20 Million - $27.3 Million	-926,378 Reduced 33.74%	1,819,584 $49.2 Million
Q3 2023 Nov 14, 2023	SELL	$25.8 - $39.97 $37.9 Million - $58.7 Million	-1,469,418 Reduced 34.86%	2,745,962 $81.4 Million
Q2 2023 Aug 14, 2023	BUY	$20.94 - $38.01 $53 Million - $96.3 Million	2,532,687 Added 150.51%	4,215,380 $151 Million
Q1 2023 May 15, 2023	SELL	$22.92 - $33.76 $464,978 - $684,889	-20,287 Reduced 1.19%	1,682,693 $39.4 Million
Q4 2022 Feb 14, 2023	BUY	$25.44 - $59.78 $2.76 Million - $6.48 Million	108,381 Added 6.8%	1,702,980 $46.3 Million
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $1.04 Million - $1.46 Million	23,857 Added 1.52%	1,594,599 $85.8 Million
Q2 2022 Aug 15, 2022	BUY	$28.82 - $77.35 $6.56 Million - $17.6 Million	227,675 Added 16.95%	1,570,742 $63.4 Million
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $1.6 Million - $3.33 Million	33,150 Added 2.53%	1,343,067 $89 Million
Q4 2021 Feb 14, 2022	SELL	$88.71 - $120.43 $164 Million - $222 Million	-1,847,006 Reduced 58.51%	1,309,917 $131 Million
Q3 2021 Nov 15, 2021	BUY	$98.77 - $132.17 $156 Million - $209 Million	1,577,628 Added 99.89%	3,156,923 $395 Million
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $4.22 Million - $6.36 Million	38,411 Added 2.49%	1,579,295 $196 Million
Q1 2021 May 17, 2021	BUY	$127.04 - $179.1 $13.8 Million - $19.4 Million	108,510 Added 7.58%	1,540,884 $235 Million
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $143 Million - $195 Million	1,432,374 New	1,432,374 $185 Million

Others Institutions Holding GH

# of Institutions

322

Shares Held

115M

Call Options Held

738K

Put Options Held

1.67M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.04B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Guardant Health, Inc. Transaction History